Webcast | Virtual
Event Title
Webinar - The Voluntary Improvement Program: How to Enroll, Opportunities, and Best Practices
October 8, 2024
- Date:
- October 8, 2024
- Time:
- 1:00 p.m. - 2:00 p.m. ET
Summary
The U.S. Food and Drug Administration (FDA) held a webinar for industry and other interested stakeholders to discuss the Voluntary Improvement Program.
During this webinar, the FDA:
- Discussed the VIP enrollment and participation criteria for manufacturing sites,
- Reviewed the value, expectations, and regulatory opportunities for participants,
- Shared best practices for submitting a 30-Day Notice, and
- Answered questions from webinar participants about the VIP.
Background
The Voluntary Improvement Program (VIP), is a voluntary program facilitated through the Medical Device Innovation Consortium (MDIC) that evaluates the capability and performance of medical device manufacturer's practices. The program utilizes third party appraisals designed to assess and enhance the quality of medical devices.
For manufacturers, the Voluntary Improvement Program provides the participating manufacturer with data and granularity that reflects its own organizational performance against the practices outlined in the maturity model, and a roadmap to improve performance, increase quality, and enhance value.
Webinar Materials
The presentation, printable slides, and transcript are available on CDRH Learn under “Postmarket Activities,” sub-section “General Policy.”
If you have questions about the Voluntary Improvement Program, please email CaseforQuality@fda.hhs.gov. If you have questions about this webinar, please contact CDRH's Division of Industry and Consumer Education (DICE) at dice@fda.hhs.gov, 1-800-638-2041, or 301-796-7100.